Protected intake, payment, prescribing, and care enrollment reopen in September.

PCOS and Infertility: Understanding the Connection

Jul 23, 2026 · 5 min readRolf Hoefer, Ph.D.

3 sources reviewedMedically reviewed by Amy Bingaman, MD, MSCP, FACOGArticle updated Jul 23, 2026Our editorial process

The short answer

The link runs through hormones and metabolism, not cysts. In polycystic ovary syndrome (PCOS), now renamed polyendocrine metabolic ovarian syndrome (PMOS), high androgen levels and often insulin resistance disrupt the signals that trigger ovulation, so eggs are released irregularly or not at all, which is why it is the most common cause of anovulation and a leading cause of infertility. [1] Because up to 70% of women with PCOS are undiagnosed, many first learn of it while trying to conceive. [1] The connection is treatable for many, and it persists as a metabolic condition well past the fertility years, so it deserves attention into midlife. [2]

What you’ll learn

  • Polycystic ovary syndrome (PCOS) is linked to infertility mainly through anovulation: hormonal imbalance, often with insulin resistance, keeps the ovary from releasing eggs regularly. [1]
  • It is the most common cause of anovulation and a leading cause of infertility, affecting an estimated 10 to 13 percent of reproductive-aged women. [1]
  • Up to 70 percent of women with the condition are undiagnosed, so infertility is often the first clue that leads to the diagnosis. [1]
  • Insulin resistance and weight are modifiable levers, which is why lifestyle and certain medicines can improve both fertility and metabolic health. [2] [3]
  • The PCOS and infertility connection is one phase of a lifelong condition whose metabolic and endometrial risks continue after menopause. [1]

The phrase "PCOS and infertility" gets used as if the link were obvious: you have polycystic ovary syndrome (PCOS), so of course fertility is hard. But understanding how the two are actually connected changes what you can do about it, and it explains why the connection does not simply end when you stop trying to conceive.

The short version is that PCOS affects fertility through hormones and metabolism, not through the "cysts" the old name implied. That is exactly why the condition was renamed polyendocrine metabolic ovarian syndrome (PMOS) in 2026: to reflect that it is a whole-body hormonal and metabolic disorder, not a problem confined to the ovaries.

The mechanism: disrupted ovulation

At the center of the connection is ovulation. The condition occurs when inappropriate hormonal signaling leads to higher-than-normal androgen levels and other hormonal imbalances. [1] Those disrupted signals can stop an egg from developing or from being released, so ovulation becomes irregular or absent. [2] Without regular ovulation, the monthly opportunity to conceive is missing, which is why the syndrome is the most common cause of anovulation and a leading cause of infertility. [1]

Insulin resistance is a frequent partner in this. It is common in PCOS and can amplify the hormonal imbalance that blocks ovulation, which is one reason weight and insulin sit at the center of both fertility and long-term health in this condition. That also makes them modifiable levers rather than fixed fate. [1]

How common, and how often missed

PCOS is both common and quietly underdiagnosed. It affects an estimated 10 to 13 percent of reproductive-aged women, and up to 70 percent of affected women worldwide do not know they have it. [1] For many women, infertility is the event that finally leads to the diagnosis, after years of irregular periods that were not fully explained.

Article table: Aspect of the connection, What the evidence shows
Aspect of the connectionWhat the evidence shows
Core mechanismDisrupted ovulation from hormonal imbalance and high androgens [1] [2]
Metabolic driverInsulin resistance is common and can worsen anovulation [1]
Prevalence10 to 13 percent of reproductive-aged women; up to 70 percent undiagnosed [1]
Modifiable leversWeight, insulin, and lifestyle; medicines can restore ovulation [3]
After menopauseMetabolic and endometrial risks persist [1]

Because weight and insulin resistance are modifiable, addressing them can improve both fertility odds and metabolic health at the same time. For how the treatment options for this condition rank, see PCOS treatments ranked by the evidence, and for the insulin-sensitizing side of the syndrome, see inositol for PCOS and metformin for PCOS after menopause.

This is the part the phrase "PCOS and infertility" hides: the connection is one chapter of a lifelong condition. Women with PCOS carry heightened long-term risk of insulin resistance, type 2 diabetes, and obesity, and the irregular periods that hurt fertility can also raise the risk of endometrial hyperplasia and endometrial cancer. [1]

Those risks do not resolve at menopause. So even after fertility is no longer the question, the same hormonal and metabolic story continues, which is why women with the condition benefit from ongoing screening of blood sugar, cardiovascular risk, and the uterine lining. See PCOS after menopause and insulin resistance and, on the same syndrome, PCOS and endometrial cancer risk.

Where the evidence is limited

It is honest to say the evidence on the connection has limits. The condition is diagnosed by a combination of features rather than a single test, and how strongly it affects any one woman's fertility varies with age, weight, insulin resistance, and other factors. [1] The strongest fertility-treatment trials studied women actively trying to conceive, so they do not answer every individual scenario. The reliable takeaways are the mechanism and the modifiable levers; the individual forecast is a clinician's judgment.

Who this fits

This overview fits women who have the condition, or suspect it, and want to understand why it affects fertility and what parts of the connection they can influence. It is especially useful for making sense of a new diagnosis discovered while trying to conceive.

It is a poor fit as a substitute for evaluation. Irregular or absent periods, difficulty conceiving, or signs of high androgens or high blood sugar are reasons to be assessed rather than to self-manage from an article.

Red flags worth attention

  • Periods that stop for several months or become very heavy or unpredictable, which needs evaluation to protect the uterine lining.
  • Difficulty conceiving after a year of trying, or six months if over 35, which warrants a fertility assessment.
  • Rising blood sugar, blood pressure, or cholesterol, which should be checked given the metabolic core of the condition.

What to ask your clinician

  1. Is the condition the reason behind my irregular periods or trouble conceiving?
  2. Do I have insulin resistance, and would treating it help my fertility and my long-term health?
  3. Which fertility treatments make sense for my age and situation?
  4. How should we protect my uterine lining if my periods are irregular?
  5. What metabolic screening do I need now and as I get older?
  6. When should I involve a fertility specialist?

Bottom line

The condition and infertility are connected through disrupted ovulation, driven by hormonal imbalance and often insulin resistance, which makes it the most common cause of anovulation and a leading cause of infertility. [1] [2] Because so many women are undiagnosed, infertility is often what finally reveals the condition. [1]

The connection is treatable for many, and its modifiable levers, weight and insulin, also protect long-term health. [3] Most importantly, the link is one phase of a lifelong condition whose metabolic and endometrial risks continue past menopause, which is why PCOS deserves attention well beyond the years of trying to conceive. [1]

References

[1] World Health Organization. Polycystic ovary syndrome. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome

[2] MedlinePlus. Polycystic Ovary Syndrome. U.S. National Library of Medicine. https://medlineplus.gov/polycysticovarysyndrome.html

[3] Teede HJ, Tay CT, Laven J, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189(2):G43-G64. https://pmc.ncbi.nlm.nih.gov/articles/PMC10505534/

Common questions

How are PCOS and infertility connected?

Through ovulation. High androgens and often insulin resistance disrupt the hormonal signals that mature and release an egg, so ovulation becomes irregular or absent. No regular ovulation makes conception harder, which is the core of the connection. [1] [2][1][2]

Does insulin resistance affect PCOS fertility?

Often, yes. Insulin resistance is common in the condition and can worsen the hormonal imbalance that blocks ovulation. That is why addressing weight and insulin, through lifestyle and sometimes medicines, can improve both fertility and long-term metabolic health. [1] [3][1][3]

Why do so many women discover PCOS through infertility?

Because it is often silent. Up to 70 percent of women with PCOS worldwide are undiagnosed, and irregular periods can be dismissed for years. Trouble conceiving frequently prompts the testing that finally names the condition. [1][1]

Does the PCOS-infertility link matter after menopause?

The fertility part ends, but the condition does not. PCOS carries lasting risks of insulin resistance, type 2 diabetes, and endometrial problems that persist and rise with age, so the connection matters as a metabolic issue well into your 40s, 50s, and beyond. [1][1]

Related in Weight loss & metabolic health

Insulin resistance & prediabetesBerberine vs Metformin: What the Evidence Actually ShowsHead-to-head, the evidence is thinner than the marketing suggests. In the main direct trial (36 adults with new type 2 diabetes), berberine (0.5 g three times daily) lowered A1c (hemoglobin A1c) and blood glucose about as much as metformin over three months. [1] A polycystic ovary syndrome (PCOS) network meta-analysis found only two small, low-quality head-to-head trials comparing them directly. [2] Metformin is FDA-approved with decades of safety data; berberine is an unregulated supplement that interacts with many medicines and is likely unsafe in pregnancy. [3] [4] Which one fits you is a clinician's call, not a supplement-aisle default.Jul 23, 2026 · 6 min readInsulin resistance & prediabetesDo PCOS Cysts Go Away? What They Really AreThe "cysts" in PCOS are not true cysts; they are small immature follicles, and about one in five women with the condition do not have them on ultrasound at all. The misunderstanding was a main reason the condition was renamed polyendocrine metabolic ovarian syndrome (PMOS) in 2026. [2] After menopause, ovulation and periods stop, so the polycystic-ovary pattern fades, but the condition itself does not go away: insulin resistance, higher androgens, and metabolic risk persist and cardiovascular risk rises. [3] So the "cysts" become less relevant with age, while the metabolic side needs ongoing attention. [3]Jul 23, 2026 · 3 min readGLP-1 medicationsDoes Compounded Semaglutide Need to Be Refrigerated?Compounded semaglutide often needs cold-chain handling, but the safe answer comes from the pharmacy label and instructions for that exact compounded product. FDA says injectable glucagon-like peptide-1 drugs require refrigeration as indicated in their package inserts and warns not to use injectable glucagon-like peptide-1 drugs that arrive warm or with insufficient refrigeration. FDA-approved Wegovy and Ozempic labels list specific refrigerator, room-temperature, light, freezing, and day limits, but those branded-label rules should not be copied onto every compounded vial without confirmation from the prescriber or compounder. [1] [2] [3]Jun 24, 2026 · 8 min readGLP-1 medicationsDoes Insurance Cover GLP-1 Weight-Loss Medication?Insurance can cover a glucagon-like peptide-1 medicine for weight loss, but coverage depends on the plan, product, indication, and prior authorization. As of July 1, 2026, Medicare has a temporary glucagon-like peptide-1 Bridge for eligible Part D beneficiaries using certain products for weight management, while other glucagon-like peptide-1 indications may run through ordinary Part D coverage. Commercial and Marketplace plans depend on formulary rules. Before paying cash, ask the plan and prescriber which diagnosis, product, dose form, prior authorization, and appeal path apply. [1] [2] [5]Jun 30, 2026 · 7 min read